Christopher Pazdan - May 12, 2025 Form 4 Insider Report for KORU Medical Systems, Inc. (KRMD)

Role
Chief Operating Officer
Signature
/s/ Thomas Adams-Attorney-in- Fact
Stock symbol
KRMD
Transactions as of
May 12, 2025
Transactions value $
$0
Form type
4
Date filed
8/11/2025, 04:25 PM
Previous filing
Mar 21, 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Pazdan Christopher Chief Operating Officer C/O KORU MEDICAL SYSTEMS, INC., 100 CORPORATE DRIVE, MAHWAH /s/ Thomas Adams-Attorney-in- Fact 2025-08-07 0002028813

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction KRMD Restricted Stock Units Award $0 +21.3K $0.00 21.3K May 12, 2025 Common Stock 21.3K Direct F1, F2, F3
transaction KRMD Restricted Stock Units Award $0 +21.3K $0.00 21.3K May 12, 2025 Common Stock 21.3K Direct F1, F2, F4
transaction KRMD Option to buy Common Stock Award $0 +36.1K $0.00 36.1K May 12, 2025 Common Stock 36.1K $3.21 Direct F1, F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each of the reported securities represent awards made pursuant to the Company's 2024 Omnibus Equity Incentive Plan in connection with the Company's 2025 Long-Term Incentive Program.
F2 Each restricted stock unit represents a contingent right to receive one share of KORU Medical Systems, Inc. (the "Company") upon vesting.
F3 One-fourth will vest on May 12, 2026 and on each first, second and third anniversary thereof or upon an earlier chance in control of the Company.
F4 These restricted stock units will vest based upon achievement of certain performance conditions as of December 31, 2027 or upon an earlier change in control of the Company. The amount reported represents the amount of shares payable at target performance; the Reporting Person could earn 0%-150% of the amount reported depending on the level of performance achieved, multiplied by between 0.5 to 1.5 times of the earned number of shares. These restricted stock units will vest at 100% of the amount reported upon a change in control of the Company prior to December 31, 2027.
F5 One-fourth will vest on May 12, 2026 and on each first, second and third anniversary thereof.

Remarks:

The filing of this statement shall not be construed as an admission (a) that the person filing this statement is, for the purposes of Section 16 of the Securities Exchange Act of 1934, as amended, the beneficial owner of any equity securities covered by this statement, or (b) that this statement is legally required to be filed by such person. Power of Attorney has been previously filed.